← TrialMatch
HomeTrials

Predicting Appendicular Lean and Fat Mass With Bioelectrical Impedance Analysis Among Adul

This study aims to develop and cross-validate novel bioelectrical impedance analysis (BIA) equations for predicting appendicular soft tissue masses, specifically fat mass (FM) and appendicular lean mass (ALM), in a sample of Caucasian adult subjects affected by obesity. The research will compare these new BIA equations

Condition(s)Obesity
StatusRecruiting
Study typeObservational
SummaryThis study aims to develop and cross-validate novel bioelectrical impedance analysis (BIA) equations for predicting appendicular soft tissue masses, specifically fat mass (FM) and appendicular lean mass (ALM), in a sample of Caucasian adult subjects affected by obesity. The research will compare these new BIA equations with three established BIA-derived prediction models and validate them using dual-energy X-ray absorptiometry (DXA) and magnetic resonance imaging (MRI) data. This study utilizes existing datasets to enhance the accuracy and applicability of BIA in assessing body composition and supports the development of standardized algorithms for converting raw BIA data across different devices and populations.
Who can participateInclusion Criteria: * Adults with obesity (BMI ≥ 30 kg/m²) * Age 18 years and older * Available baseline DXA and BIA measurements * Provided informed consent for data use Exclusion Criteria: * any chronic disease or medication that can significantly affect body composition \[eg. malignant diseases in the last 5 years, organ failure, acute inflammation (C-reactive protein\>10 mg/L) autoimmune diseases, neurological diseases, syndromic obesity\] * cognitive impairment (Mini-Mental State Examination \<25) * subjects that are considered physically active (athletes or very active subjects i.e., performing at least 150 minutes of moderate to vigorous physical activity per week) * alcohol intake \>140g/wk for Males and 70g/wk for Females * participation in a weight-reducing program (last 3 months
Ages18 Years
SexAll
Lead sponsorUniversity of Roma La Sapienza
LocationsBaton Rouge, Louisiana, United States; Chapel Hill, North Carolina, United States; Perth, Australia; Pelotas, Rio Grande do Sul, Brazil; Edmonton, Alberta, Canada; Cagliari, Italy (+3 more sites)
Start date2021-05-13
NCT IDNCT06545435
Official listinghttps://clinicaltrials.gov/study/NCT06545435

🔍 Search all trials →